Drug Database
Back to search

Germany· DE-A57-d092a4e7877eaa41

Voriconazol Beta

A voriconazole product containing voriconazole, registered in Germany by Betapharm Arzneimittel Gmbh. The same ATC class is registered in 18 of our 19 countries.

ATC J02AC03

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedVoriconazol BetaATCJ02AC03REGISTER NO.DE-A57-d092a4e7877eaa…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about voriconazoleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Voriconazole is registered in 18 of 19 countries.

Countries holding a registration under ATC J02AC03 (voriconazole), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 10 of them publish a price we can compare per daily dose
Search voriconazole products by name

Voriconazole · ATC J02AC03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of voriconazole costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.14 in Czechia to $86.21 in Switzerland — a ×609 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Voriconazole · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$86.21
  • FR France$38.90
  • IT Italy$12.20
  • US United States$3.77 (acquisition cost)
  • CZ Czechia$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Voriconazole
Manufacturer
Betapharm Arzneimittel Gmbh
Country
Germany (DE)
ATC code
J02AC03
ATC class
Voriconazole
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

513 interactions on record for voriconazole.

Graded by severity as the source publishes them — 161 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check voriconazole against other medicinesHow interaction checks work

Voriconazole · interactions on record

513 records

  • 161 severe
  • 229 moderate
  • 10 minor
  • 48 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

65 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Voriconazole in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All voriconazole products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Voriconazol Accord, Voriconazol Accordpharma
  • Belgium · Voriconazol Eg, Voriconazol Fosun Pharma
  • Bulgaria · Voriconazole Sandoz, Voriconazole Sanexcel
  • Cyprus · Vedida, Voriconazole Accord
  • Czechia · Voriconazol Viatris, Voriconazole Accord
  • Denmark · Voriconazol "denk", Voriconazol Accordpharma
  • Estonia · Vedida, Voriconazole Accord
  • Spain · Voriconazol Accord, Voriconazol Aurovitas
  • Finland · Voriconazol Accordpharma, Voriconazole Accord
  • France · Voriconazole Accord, Voriconazole Amarox
  • United Kingdom (Northern Ireland) · Voriconazole, Voriconazole Accord
  • Greece · Aetopia, Voriconazole Aenorasis
  • Croatia · Voramol, Vorikonazol Accordpharma
  • Hungary · Voriconazole Accord, Voriconazole Onkogen
  • Ireland · Voriconazole, Voriconazole Accord
  • Iceland · Vfend, Voriconazol Accordpharma
  • Italy · Voriconazolo Amarox, Voriconazolo Aurobindo
  • Liechtenstein · Vfend, Voriconazole Accord
  • Lithuania · Voriconazole Accord Healthcare, Voriconazole Teva
  • Luxembourg · Voriconazol Eg, Voriconazol Renantos Stada Arzneimittel Ag
  • Latvia · Voriconazole Accord Healthcare, Voriconazole Elpen
  • Malta · Voriconazole Ahcl, Voriconazole Ibisqus
  • Netherlands · Verria, Voramol
  • Norway · Vfend, Voriconazol Accordpharma
  • Poland · Voriconazol Polpharma, Voriconazole Accord
  • Portugal · Voriconazol Accord, Voriconazol Aristo
  • Romania · Vedida, Voramol
  • Sweden · Voriconazole Accord, Voriconazole Fresenius Kabi
  • Slovenia · Vorikonazol Accord, Vorikonazol Accordpharma
  • Slovakia · Vedida, Voriconazol Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5584a8c-fe1d-402b-9b53-12bd38d085fe
GET /v1/drugs/c5584a8c-fe1d-402b-9b53-12bd38d085fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Voriconazole",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about voriconazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console